Journal of International Oncology››2012,Vol. 39››Issue (7): 526-529.
Previous ArticlesNext Articles
YIN Jun, LI Tao
Online:
2012-08-06Published:
2012-08-06Contact:
LI Tao, E-mail: litaoxmf@126.com E-mail:litaoxmf@126.comYIN Jun, LI Tao. Individual comprehensive therapy study for esophageal carcinoma[J]. Journal of International Oncology, 2012, 39(7): 526-529.
[1] | Yang Mi, Bie Jun, Zhang Jiayong, Deng Jiaxiu, Tang Zuge, Lu Jun.Analysis of the efficacy and prognosis of neoadjuvant therapy for locally advanced resectable esophageal cancer[J]. Journal of International Oncology, 2024, 51(6): 332-337. |
[2] | Liu Jing, Liu Qin, Huang Mei.Prognostic model construction of lung infection in patients with chemoradiotherapy for esophageal cancer based on SMOTE algorithm[J]. Journal of International Oncology, 2024, 51(5): 267-273. |
[3] | Wan Fang, Yang Gang, Li Rui, Wan Qijing.Expression levels and clinical significance of serum miR-497 and miR-383 in patients with esophageal cancer[J]. Journal of International Oncology, 2024, 51(4): 204-209. |
[4] | Gao Xinyu, Li Zhenjiang, Sun Hongfu, Han Dan, Zhao Qian, Liu Chengxin, Huang Wei.Clinical application of MR-guided radiotherapy based on MR-linac in esophageal cancer patients[J]. Journal of International Oncology, 2024, 51(1): 37-42. |
[5] | Shandong Medical Association Multidisciplinary Joint Committee on Lung Cancer.Shandong Provincial Medical Association multidisciplinary standardized diagnosis and treatment guidelines for esophageal carcinoma (2023 Edition)[J]. Journal of International Oncology, 2023, 50(7): 385-397. |
[6] | Ji Shiyu, Zhang Mingxin, Xie Huahong, Bai Yuan, Wang Tong.Observation on the efficacy of different stents in the treatment of patients with advanced esophageal cancer[J]. Journal of International Oncology, 2023, 50(2): 76-81. |
[7] | Gong Heyi, Yi Yan, Zhang Jian, Li Baosheng.Management strategies for locally advanced operable esophageal carcinoma achieving clinical complete response after neoadjuvant chemoradiotherapy[J]. Journal of International Oncology, 2023, 50(12): 745-750. |
[8] | Tian Jinming, Yang Jijin.Research progress of locoregional interventional therapies combined with immune checkpoint inhibitors for intermediate-advanced hepatocellular carcinoma[J]. Journal of International Oncology, 2023, 50(10): 636-640. |
[9] | Song Jia, Hu Qinyong.Application of TACE combined with molecular targeted therapy and immunotherapy in BCLC B/C hepatocellular carcinoma[J]. Journal of International Oncology, 2022, 49(9): 550-554. |
[10] | Wu Puyuan, Qi Liang, Wang Tao, Shi Minke, Sun Yuwei, Wang Lifeng, Liu Baorui, Yan Jing, Ren Wei.Efficacy of postoperative radiotherapy based on modified clinical target volume according to high-frequency recurrence regions in patients with esophageal squamous cell carcinoma[J]. Journal of International Oncology, 2022, 49(8): 464-472. |
[11] | Xia Lingling, Chen Yongshun, Li Bin, Ning Tingting, Zhang Caiyutian.Comparison of safety and efficacy between chemoradiotherapy and chemotherapy after R0 resection in pN+esophageal squamous cell carcinoma patients[J]. Journal of International Oncology, 2022, 49(6): 334-339. |
[12] | Ye Qian, Ling Zhi, Liu Shenxiang, Lu Guotao, Yin Xudong.Effects of sarcopenia on the clinical efficacy and prognosis of radical radiotherapy in elderly patients with esophageal cancer[J]. Journal of International Oncology, 2022, 49(4): 199-205. |
[13] | Zhang Rui, Feng Enzi, Ren Yanxin, Li Xiaojiang.Advances in non-operative treatment of advanced hypopharyngeal squamous cell carcinoma[J]. Journal of International Oncology, 2022, 49(4): 233-236. |
[14] | Zhou Jianfeng, Wang Tiejun.Targeted therapy and immunotherapy of esophageal cancer[J]. Journal of International Oncology, 2022, 49(4): 237-242. |
[15] | Gao Min, Feng Jing, Wang Li, Zhong Hai, Wen Yuting, Wan Bing, Zhang Xiuwei.Application of microbiota in the early diagnosis and adjunctive treatment of lung cancer[J]. Journal of International Oncology, 2022, 49(4): 247-251. |
Viewed | ||||||
Full text |
|
|||||
Abstract |
|
|||||